NCT07173829View on ClinicalTrials.gov

A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression

Not yet recruitingOBSERVATIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2030

Conditions
Glioblastoma
Interventions
OTHER

samples

A 50 ml blood sample will be taken from the patient before the operation, and two 0.3 cm3 tumor samples will be taken during the operation from the resected tumor.

All Listed Sponsors
collaborator

University of Bordeaux

OTHER

lead

University Hospital, Bordeaux

OTHER

NCT07173829 - A Study to Better Understand the Biological and Molecular Mechanisms Involved in Glioblastoma Recurrence and Progression | Biotech Hunter | Biotech Hunter